OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
Dena Firouzabadi, Fatemeh Kheshti, Saeed Abdollahifard, et al.
Health Science Reports (2022) Vol. 5, Iss. 6
Open Access | Times Cited: 13
Dena Firouzabadi, Fatemeh Kheshti, Saeed Abdollahifard, et al.
Health Science Reports (2022) Vol. 5, Iss. 6
Open Access | Times Cited: 13
Showing 13 citing articles:
SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors
Emad Behboudi, Seyed Nooreddin Faraji, Gholamreza Daryabor, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26577-e26577
Open Access | Times Cited: 6
Emad Behboudi, Seyed Nooreddin Faraji, Gholamreza Daryabor, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26577-e26577
Open Access | Times Cited: 6
Lithium and the risk of severe COVID-19 infection: A retrospective population-based register study
Niklas Nilsson, Marie Bendix, Louise Öhlund, et al.
Journal of Psychosomatic Research (2025) Vol. 190, pp. 112053-112053
Open Access
Niklas Nilsson, Marie Bendix, Louise Öhlund, et al.
Journal of Psychosomatic Research (2025) Vol. 190, pp. 112053-112053
Open Access
COVID-19 mortality among selective serotonin reuptake inhibitor users—results from a nationwide cohort
Marius Ahm Stauning, Dogukan Jesper Gür, Christian Torp‐Pedersen, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 8, pp. 1075-1082
Open Access | Times Cited: 11
Marius Ahm Stauning, Dogukan Jesper Gür, Christian Torp‐Pedersen, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 8, pp. 1075-1082
Open Access | Times Cited: 11
Inhibitory effects of fluoxetine on the secretion of inflammatory mediators and JAK/STAT3 and JNK/TLR4 gene expression
Hoda Mojiri-Forushani, Elham Khajehali, Maryam Adelipour, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 3, pp. 2231-2241
Open Access | Times Cited: 12
Hoda Mojiri-Forushani, Elham Khajehali, Maryam Adelipour, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 3, pp. 2231-2241
Open Access | Times Cited: 12
The effectiveness and tolerability of agomelatine in the treatment of depression after COVID-19 infection in Russian daily clinical practice (TELESPHOR study)
В Э Медведев, А Н Боголепова, Denis P. Morozov, et al.
Authorea (Authorea) (2024)
Open Access | Times Cited: 1
В Э Медведев, А Н Боголепова, Denis P. Morozov, et al.
Authorea (Authorea) (2024)
Open Access | Times Cited: 1
Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID – Ein Scoping-Review Update
Udo Bonnet, Georg Juckel
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1
Udo Bonnet, Georg Juckel
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1
Is There such a Thing as Post-Viral Depression?: Implications for Precision Medicine
Eun‐Sook Park, Chan Young Shin, Se Jin Jeon, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 6, pp. 659-684
Closed Access | Times Cited: 1
Eun‐Sook Park, Chan Young Shin, Se Jin Jeon, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 6, pp. 659-684
Closed Access | Times Cited: 1
Duloxetine hydrochloride enteric-coated pellets in capsules with delayed release: formulation and evaluation
Ramya Krishna Nakkala, Balaji Maddiboyina, Shanmukha Chakravarthi Bolisetti, et al.
Smart Science (2023) Vol. 11, Iss. 3, pp. 434-446
Closed Access | Times Cited: 3
Ramya Krishna Nakkala, Balaji Maddiboyina, Shanmukha Chakravarthi Bolisetti, et al.
Smart Science (2023) Vol. 11, Iss. 3, pp. 434-446
Closed Access | Times Cited: 3
Health-Related Quality of Life (HRQoL) in COVID-19 Patients After Recovering from the Acute Infection
Dena Firouzabadi, Laleh Mahmoudi, Maryam Kadkhodamohammadi, et al.
Archives of Pediatric Infectious Diseases (2024) Vol. 12, Iss. 4
Open Access
Dena Firouzabadi, Laleh Mahmoudi, Maryam Kadkhodamohammadi, et al.
Archives of Pediatric Infectious Diseases (2024) Vol. 12, Iss. 4
Open Access
Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR)
Константин Быков, А Н Боголепова, Denis P. Morozov, et al.
Neurology neuropsychiatry Psychosomatics (2024) Vol. 16, Iss. 6, pp. 61-70
Open Access
Константин Быков, А Н Боголепова, Denis P. Morozov, et al.
Neurology neuropsychiatry Psychosomatics (2024) Vol. 16, Iss. 6, pp. 61-70
Open Access
COVID-19 as a polymorphic inflammatory spectrum of diseases: a review with focus on the brain
Siu Wa Tang, Daiga M. Helmeste, Brian E. Leonard
Acta Neuropsychiatrica (2023) Vol. 35, Iss. 5, pp. 248-269
Open Access | Times Cited: 1
Siu Wa Tang, Daiga M. Helmeste, Brian E. Leonard
Acta Neuropsychiatrica (2023) Vol. 35, Iss. 5, pp. 248-269
Open Access | Times Cited: 1
Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
Udo Bonnet
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1
Udo Bonnet
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1
